Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
clinical trials
life sciences
national blog main
boston blog main
boston top stories
fda
alexion pharmaceuticals
amyotrophic lateral sclerosis (als)
boston
deals
national top stories
san diego blog main
san diego top stories
abbvie
aimmune therapeutics
akcea therapeutics
akebia therapeutics
alex pinto
alnylam
alnylam pharmaceuticals
amarin pharma
amarna therapeutics
amylyx
anemia
antibody drug
arena pharmaceuticals
artie suckow
autoimmune disorders
biofourmis
boehringer ingelheim
boston pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
casdin capital
chronic kidney disease
clene nanomedicine
complement system
corvex management
What
pharma
4
×
medicines
disease
drug
pharmaceuticals
abbvie’s
advance
ahead
alternative
autoimmune
bio
biofourmis
biologics
bucks
cancer
candidate
caught
causing
celebrate
chance
considered
corner
day
days
deal
deliver
dicerna
diseases
drugs
dtx
expensive
eye
forward
gene
hepatitis
hitting
holiday
intended
labor
lead
Language
unset
4
×
Current search:
pharma
×
unset
×
biotech
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
